# WiseDiag

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/wisediag

- Industry: Healthcare IT
- Headquarters: Hangzhou, China
- Website: www.wisediag.com
- Total disclosed funding: $9.5M
- Latest round: Angel (May 6, 2026)
- Investors on record: 3

## About

Based in Zhejiang, China and founded in 2023, Hangzhou Zhizhen Technology Co., Ltd., trading as WiseDiag, is focusing on developing advanced healthcare technologies. In September 2026, WiseDiag raised CNY 53 million in Pre-series A funding led by Zhejiang Redrock Group, with participation from Sinowisdom, Hangzhou Cheng'an Enterprise Management Partnership and other investors.

WiseDiag primarily offers advanced AI-driven healthcare solutions, including its flagship products: the WiseDiag medical multimodal model, the Haoban AI intelligent health management application, and the WiseClaw AI agent platform. The WiseDiag model utilizes deep learning and dual architecture for multi-modal diagnosis, supporting medical institutions with AI insights and treatment recommendations. The Haoban AI app acts as a personal health assistant, proactively identifying health risks and providing personalized lifestyle suggestions. The company serves over 300 hospitals and medical institutions across China, expanding its influence in telemedicine and health technology sectors.

WiseDiag generates revenue through B2B partnerships with healthcare institutions and direct-to-consumer subscriptions for its applications. 

The company will use the latest funding to continuously iterate the WiseDiag medical large model, advance intelligent products and solutions for the healthcare industry, and upgrade "Haoban AI" for individuals and families.

## Funding rounds

- Angel, May 6, 2026, $9.5M — Sinowisdom, Lanshan Capital, Wuxi Huishan State-Owned Investment Holding Group

## Investors

- Sinowisdom (https://capitalatlas.ai/funds/sinowisdom) — Angel
- Lanshan Capital (https://capitalatlas.ai/funds/lanshan-capital) — Angel
- Wuxi Huishan State-Owned Investment Holding Group — Angel